In return, this not only assists with weight loss but also increases insulin sensitivity and decreases free fatty acids and de novo lipogenesis [10], all of which play a role in the pathophysiology of developing MASLD. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.